Accès ouvert
2025
article
OpenAlex
Akshay S. Desai, Adam Karns, Jolita Badarienė, Ahmad Aswad et autres
Importance: In prior monotherapy studies of patients with hypertension, single subcutaneous doses of zilebesiran, an investigational RNA interference therapeutic, reduced serum angiotensinogen levels and systolic blood pressure (SBP) at 3 and 6 months. Objective: To evaluate the efficacy and safety of zilebesiran …
us, lt, gb
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
George L. Bakris, Manish Saxena, Anil Gupta, Fadi Chalhoub et autres
Importance: Angiotensinogen is the most upstream precursor of the renin-angiotensin-aldosterone system, a key pathway in blood pressure (BP) regulation. Zilebesiran, an investigational RNA interference therapeutic, targets hepatic angiotensinogen synthesis. Objective: To evaluate antihypertensive efficacy and safety of different zilebesiran dosing regimens. Design, …
us, gb
(code pays fourni par la source)
Accès ouvert
2015
article
OpenAlex
Roberta Ara, Suzy Paisley, Adam Robinson, Ahmed Azough et autres
gb
(code pays fourni par la source)
2007
article
OpenAlex
John C. Jeffery, T. Riis‐Johannessen, Callum J. Anderson, Christopher J. Adams et autres
The coordination chemistry of the tetradentate pyridyl-thiazole (py-tz) N-donor ligand 6,6'-bis(4-phenylthiazol-2-yl)-2,2'-bipyridine (L1) has been investigated. Reaction of L1 with equimolar copper(II) ions results in the formation of the single-stranded mononuclear complex [Cu(L1)(ClO4)2] (1), whereas reaction with copper(I) ions results in the double-stranded …
gb
(code pays fourni par la source)